30
CARDIOVASCULAR
hamburger
amplatzer occluder banner

Effective PFO Closure Made Easier1

Over 20 years ago, we pioneered PFO closure with the Amplatzer™ PFO Occluder. Today, it is the most-studied — and most-trusted — device of its kind, with over 180,000 patients treated worldwide.2

And our clinical evidence is unmatched, thanks to the largest-ever trial for PFO closure, boasting 5,810 patient-years of data.3

With the introduction of the Amplatzer Talisman PFO Occluder, we have built upon the proven Amplatzer PFO closure technology. The occluder now comes assembled and ready to use, simplifying prep and enhancing ease-of-use. And we've refined the 30mm size to have a smaller left atrial disc to better avoid interference with surrounding structures.
The easy-to-use just got easier.

Amplatzer Talisman PFO Occluder
Amplatzer Portfolio App

NEW VERSION AVAILABLE
GET THE AMPLATZER™ PORTFOLIO APP

The Amplatzer™ App helps physicians choose the right Amplatzer™ device to meet the needs of each case.

Learn more about Amplatzer™ Talisman™ PFO Occluder.

Ordering Information

SIZING AND DEVICE SELECTION
Amplatzer™ Talisman™ PFO Occluder
Model/Reorder Number Right Atrial Disc Diameter
A
Left Atrial Disc Diameter
B
Recommended Sheath Size
9-PFO-1818 18 mm 18 mm 8 F; 45° curve
9-PFO-2518 25 mm 18 mm 8 F; 45° curve
9-PFO-3025 30 mm 25 mm 9 F; 45° curve
9-PFO-3525 35 mm 25 mm 9 F; 45° curve
Amplatzer PFO
DELIVERY SHEATH
Amplatzer™ Talisman™ Delivery Sheath
Model/Reorder Number Sheath Size Tip Angle Sheath Inner Diameter Sheath Outer Diameter Usable Length
9-TDS-08F45-80 8 F 45° 2.69 mm 3.45 mm 80 cm
9-TDS-09F45-80 9 F 45° 3.00 mm 3.81 mm 80 cm
ANCILLARY PRODUCTS
Amplatzer™ Guidewire
Model/Reorder Number Diameter Body Tip Description Usable Length
9-GW-002 0.035 inch Super Stiff 1.55 mm, Modified J-tip 260 cm
DEVICE SIZING GUIDELINES
PFO Morphology Example Anatomical Characteristics Suggested Amplatzer Talisman PFO Occluder size (mm)
Simple PFO or PFO with a non-prominent ASA
PFO where a secure device position and effective PFO closure can be achieved when using the 25 mm device size
  1. Absence of ASA, long tunnel, and thickened septum secundum
  2. Non-prominent ASA (<20 mm total excursion) without a long tunnel (≥ 10 mm length) and without a thickened septum secundum (≥ 10 mm thickness)
25
Complex PFO
PFO with one or more anatomical characteristics that may complicate the ability to achieve a secure device position and effective PFO closure when using the 25 mm device size
  1. ASA (≥ 10 mm excursion) with long tunnel (≥ 10 mm length)
  2. ASA (≥ 10 mm excursion) with thickened septum secundum (≥ 10 mm thickness)
  3. Prominent ASA with excessive mobility (≥ 20 mm total excursion)
  4. Lipomatous hypertrophy of septum secundum (≥ 15 mm thickness)
30 or 35
PFO with small anatomy
Anatomy not suitable for 25 mm device size secondary to interference with adjacent cardiac structures
  1. Septal primum length < 20 mm
18

Note: Evaluate the position of the device after deployment, but before detachment. Use echocardiography to ensure that the device does not impinge on the free atrial wall or aortic root. If the device interferes with an adjacent cardiac structure (such as free atrial wall or aortic root), recapture the device and redeploy. If device position remains unsatisfactory, recapture the device and either replace with a smaller device (18 mm or 25 mm) or refer the patient for alternative treatment.

The presence of an ASA alone does not necessarily prevent successful PFO closure with a 25 mm device size. In RESPECT1, 180 patients (36%) in the device closure group had an ASA. The 25 mm device size was used in the majority of patients with an ASA (77%) to close the PFO, and at 6-months post-implant, effective closure was achieved in 95% of these patients. There were no cases of device embolization in any patient in the study

1. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-32.
 
Amplatzer Amulet LAA

References

  1. Tests performed by and data on file at Abbott.
  2. Abbott data on file.
  3. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017; 377: 1022-32.

MAT-2010368 v2.0 | Item approved for OUS use only.

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.